slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 63,121-63,150
Pages 2,605
Rows per page 30
Component
63,121-63,150 of 78,138
09
The slide uses a color-coded column layout to contrast fund performance against benchmarks.Apollo Global Management | Investor Presentation Deck | 44 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
16
The chart shows a clear inverse relationship between the growth of corporate bond supply and the shrinking capacity of primary dealers to hold that inventory.Apollo Global Management | Investor Presentation Deck | 44 slides · Apollo Global Management
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
17
The slide uses a stacked bar chart to illustrate the transition from traditional asset classes to 'alternative' versions of those classes.Apollo Global Management | Investor Presentation Deck | 44 slides · Apollo Global Management
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
24
The chart shows growth across three segments: Traditional, HGA & Large Cap Origination, and Platforms.Apollo Global Management | Investor Presentation Deck | 44 slides · Apollo Global Management
Pitch deck Investor relations Beat · Solution1 hit
25
The slide uses a bar chart to show historical growth and a future target, alongside a list of strategic benefits and client logos.Apollo Global Management | Investor Presentation Deck | 44 slides · Apollo Global Management
Pitch deck Investor relations Beat · Solution1 hit
29
The slide uses a mathematical equation format (FRE + SRE = Fee & Spread Related Earnings + PII = Adjusted Net Income) to illustrate financial growth targets.Apollo Global Management | Investor Presentation Deck | 44 slides · Apollo Global Management
Pitch deck Investor relations Beat · Business Model1 hit
13
The chart displays two distinct time series: annual (2018-LTM 2Q'23) and quarterly (3Q'22-2Q'23).Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
20
Includes a table of gross returns and a waterfall bridge chart for performance fees.Apollo Global Management | Results Presentation Deck | 41 slides · Apollo Global Management
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to show drug development stages.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
09
The slide highlights the mechanism of action targeting multiple HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
12
The slide displays six longitudinal line charts representing different patient cohorts, with specific callouts for clinical outcomes.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
13
Clinical trial data showing individual patient responses over time.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
13
Kaplan-Meier curve shows probability of no relapse over 48 weeks for Vyvgart Hytrulo vs Placebo.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
06
Includes year-over-year growth percentages and margin expansion details.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
11
The chart shows quarterly Net Revenue and Adjusted EBITDA for the portfolio from Q1 2022 to Q2 2023.Azerion | Results Presentation Deck | 19 slides · Azerion
Conference presentation Investor relations 1 hit
19
The chart includes a callout box summarizing total debt, restricted vs. unrestricted amounts, and recent changes in restricted debt levels.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
08
The slide uses a horizontal bar chart integrated into a table to represent clinical trial phases.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Solution1 hit
17
The chart is a classic waterfall plot used in oncology to show tumor shrinkage/growth.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
19
Data cut-off Jan 4, 2023. Includes partial and complete responses.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Traction1 hit
26
The chart highlights a specific patient case with a partial response (PR) and notes a suboptimal dose case.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
28
The chart tracks % change in target lesions over time (weeks) for two specific patients.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
35
The slide uses a combination of a summary table for clinical endpoints and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
38
The slide uses a before-after-bridge style comparison between the problem (toxicity) and the solution (BA3182).BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
43
The chart uses a log scale for the Y-axis. The legend defines the three regimens: Q2W, 2Q3W, and 3Q4W.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations 1 hit
12
The chart displays a dual-axis style visualization (bar for revenue, line for customers) within a single plot area.Blue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
05
The slide uses a process diagram to contrast current clinical workflows with the proposed solution, followed by a bar chart illustrating the exponential mortality risk over time.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The table highlights NPV as the key differentiator. The ROC chart visually confirms IL-6's superior AUC.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a Gantt-style chart to show the progress of three different diagnostic tests across four development phases.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
04
The slide uses a Gantt-style chart to represent drug development progress.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes a Kaplan-Meier survival curve, an anatomical illustration of tumor locations, and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit